Celtek Bioscience is a biotechnology company focusing on R & D of cell-based technologies and products
leading to the development of novel therapeutic drugs and preventive medicines. It specializes in development of novel agents
that facilitate intracellular delivery of target compositions.
Our peptide-based, preclinical drug products are
characterized by their ability to penetrate cell membranes, which distinguishes them from other available biomedical peptides
that are usually cell impermeable. Because of this unique transport activity, our products are expected to be more valuable
in applications to cell-related disease control and prevention. They can also be useful for biomedical research and diagnosis
aimed at intracellular targets. Our goals are to provide peptide-based, preclinical drug compounds and to develop new cellular
delivery technologies useful for drug discovery and development.